DUBLIN--(BUSINESS WIRE)--The "Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.
This report on the global atrial fibrillation market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031.
Companies Mentioned
- Agilent Technologies, Inc.
- Allied Healthcare Products, Inc.
- CareFusion Corporation
- Covidien plc
- GE Healthcare Ltd.
- GF Health Products, Inc.
- Omron Healthcare, Inc.
- PARI Respiratory Equipment, Inc.
- Philips Healthcare
The report provides revenue of the global atrial fibrillation market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atrial fibrillation market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the atrial fibrillation market.
Secondary research also included internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atrial fibrillation market.
The report Incudes an elaborate executive summary, along with a snapshot of the growth behavior of various segments Incuded in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global atrial fibrillation market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atrial fibrillation market.
The report delves into the competitive landscape of the global atrial fibrillation market. Key players operating in the global atrial fibrillation market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global atrial fibrillation market profiled in this report.
Key Topics Covered:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Atrial Fibrillation Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Atrial Fibrillation Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Developments
5.2. Disease Prevalence & Incidence Rate, by Region/Globally
5.3. Atrial Fibrillation Overview
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Atrial Fibrillation Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2017-2031
6.3.1. Pharmacological Treatment
6.3.1.1. Anti-arrhythmic Drugs
6.3.1.2. Anti-coagulant Drugs
6.3.2. Non-pharmacological Treatment
6.3.2.1. Catheter Ablation
6.3.2.1.1. Radiofrequency Based
6.3.2.1.2. Cryoablation Based
6.3.2.1.3. HIFU (High Intensity Focused Ultrasound) Based
6.3.2.1.4. Microwave Based
6.3.2.1.5. Laser Based
6.3.2.2. Maze Surgery
6.3.2.3. Electric Cardioversion
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Atrial Fibrillation Market Analysis and Forecast, by Region
8. North America Atrial Fibrillation Market Analysis and Forecast
9. Europe Atrial Fibrillation Market Analysis and Forecast
10. Asia Pacific Atrial Fibrillation Market Analysis and Forecast
11. Latin America Atrial Fibrillation Market Analysis and Forecast
12. Middle East & Africa Atrial Fibrillation Market Analysis and Forecast
13. Competition Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/kj1m9d
